Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1292
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00911820 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | ||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | ||
| NCT05383196 | Onvansertib + Paclitaxel In TNBC | ||
| NCT00476086 | Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus | ||
| NCT01494662 | HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | ||
| NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
| NCT00644202 | A Pilot Weight Control Intervention at HPHC | ||
| NCT02466061 | TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors | ||
| NCT02981940 | A Study of Abemaciclib in Recurrent Glioblastoma | ||
| NCT02657343 | An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. | ||
| NCT02795858 | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors | ||
| NCT01754025 | INHERIT EGFR - Studying Germline EGFR Mutations | ||
| NCT04846478 | Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC | ||
| NCT07123090 | A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma | ||
| NCT02499497 | A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer | ||
| NCT00139191 | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | ||
| NCT04448886 | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC | ||
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | ||
| NCT03833934 | Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance | ||
| NCT05292664 | Venetoclax Basket Trial for High Risk Hematologic Malignancies | ||
| NCT02478164 | Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma | ||
| NCT04627064 | ABEMA Alone or in COMBO With MK-6482 | ||
| NCT01841879 | Mumbai Worksite Tobacco Control Study | ||
| NCT06333262 | Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia | ||
| NCT03783546 | Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial | ||
| NCT04115059 | Dasatinib In Waldenström Macroglobulinemia | ||
| NCT00580242 | A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia | ||
| NCT06015659 | ZN-c3 + Gemcitabine in Pancreatic Cancer | ||
| NCT03203473 | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) | ||
| NCT05168930 | Zanubrutinib and Venetoclax in CLL (ZANU-VEN) | ||
| NCT02040857 | Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer | ||
| NCT03689595 | Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) | ||
| NCT00859222 | LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma | ||
| NCT01942837 | Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer | ||
| NCT05587439 | Investigating Hereditary Risk In Thoracic Cancers (INHERIT) | ||
| NCT01829217 | Sunitinib in Never-Smokers With Lung Adenocarcinoma | ||
| NCT06623110 | Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease | ||
| NCT03331406 | Physical Activity In Gastrointestinal Cancer | ||
| NCT02251548 | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia | ||
| NCT02164240 | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST | ||
| NCT02774850 | Home Away From Home - Medical Outcomes | ||
| NCT00101075 | Title XELOX FOR SALIVARY GLAND CANCERS | ||
| NCT07439211 | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia | ||
| NCT01366092 | Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease | ||
| NCT01970696 | International Ovarian & Testicular Stromal Tumor Registry | ||
| NCT04917796 | The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) | ||
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | ||
| NCT00400946 | 05-001: Treatment of Acute Lymphoblastic Leukemia in Children | ||
| NCT02279394 | E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma | ||
| NCT00251394 | Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma |
